This will be followed by the clinical trial of children in the age group of two to six years
The recruitment for the clinical trial of the country’s first indigenously-developed COVID-19 vaccine, Covaxin, among children in the age group of 6-12 years will begin at the AIIMS in New Delhi. This will be followed by the clinical trial of children in the age group of two to six years.
The enrolment of children volunteers aged 12-18 years at the All India Institute of Medical Sciences (AIIMS) has been completed and they have been given the first dose of Covaxin.
“The recruitment process for the clinical trial of Covaxin among children in the age group of 6-12 years will begin from Tuesday,” Dr Sanjay Rai, Professor at the Centre for Community Medicine at the AIIMS.
The Drugs Controller General of India (DCGI) had granted permission for conducting the phase 2/3 clinical trial of Bharat Biotech’s Covaxin among children aged two to 18 years on May 12.
PTI
